|
|
|
|
| LEADER |
02922nam a2200241 u 4500 |
| 001 |
EB002001797 |
| 003 |
EBX01000000000000001164698 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Morrow, Allison S.
|
| 245 |
0 |
0 |
|a EPC pilot project
|h Elektronische Ressource
|b a dual approach to facilitate health systems uptake of evidence synthesis reports. Anxiety in children
|c investigators, Allison S. Morrow, Stephen P. Whiteside, Leslie Sim, Juan P. Brito, Zhen Wang, M. Hassan Murad
|
| 260 |
|
|
|a Rockville, MD
|b Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services
|c 2018, October 2018
|
| 300 |
|
|
|a 1 PDF file (various pagings)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 710 |
2 |
|
|a Mayo Clinic Evidence-based Practice Center
|
| 710 |
2 |
|
|a United States
|b Agency for Healthcare Research and Quality
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a Methods research report
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK531922
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a OBJECTIVE: To develop tools that can facilitate uptake of evidence synthesis reports by health systems. DATA SOURCE: We used a published evidence report on anxiety in children. We conducted a non-systematic review of Pubmed, searched the Internet and interviewed experts and other stakeholders for literature on factors essential for treatment decision-making. METHODS: We followed a dual approach in which we developed two tools, one for the health system (based on the Evidence to Decision Framework) and the second for the clinical encounter (a shared decision-making tool). The tools provided contextual and implementation information for stakeholders. RESULTS: A health system decision aid (DA) was produced as a hard copy and provided information on which patients are candidate for treatment, values and preferences, costs and resources, acceptability, impact on health equity, feasibility, drug dosing, psychotherapies other than cognitive behavioral therapy, remission rates and prognosis of anxiety in children. Health system stakeholders found the DA useful and generalizable to other conditions. The encounter DA was produced as cards containing information on issues that drive treatment decisions (effect on symptoms, effect on function, treatment burden, side effects and cost). Patients and parents prioritized the cards and chose the order in which these issues were discussed with clinician. The encounter DA was found to be helpful by patients, parents and clinicians. CONCLUSION: A dual approach addressing health system stakeholders as well as clinicians and patients can provide practical information beyond what is traditionally contained in evidence synthesis reports. This approach is likely feasible and may facilitate uptake of evidence reports by health systems
|